THE PHARMACOKINETICS AND ABSORPTION OF RECOMBINANT HUMAN RELAXIN IN NONPREGNANT RABBITS AND RHESUS-MONKEYS AFTER INTRAVENOUS AND INTRAVAGINAL ADMINISTRATION

被引:14
作者
CHEN, SA
REED, B
NGUYEN, T
GAYLORD, N
FULLER, GB
MORDENTI, J
机构
[1] GENENTECH INC,DEPT MED & ANALYT CHEM,S SAN FRANCISCO,CA 94080
[2] GENENTECH INC,DEPT PHARMACEUT R&D,S SAN FRANCISCO,CA 94080
[3] NEW MEXICO STATE UNIV,NEW MEXICO REG PRIMATE RES LABS,HOLLOMAN AFB,NM 88330
关键词
RELAXIN; PHARMACOKINETICS; ABSORPTION; INTRAVENOUS ADMINISTRATION; INTRAVAGINAL ADMINISTRATION;
D O I
10.1023/A:1018982726441
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Recombinant human relaxin (rhR1x) is being developed as a potential cervical ripening agent to be applied intravaginally or intracervically prior to parturition. The pharmacokinetics and absorption of rhR1x were determined in nonpregnant female rabbits and rhesus monkeys after intravenous bolus (iv) and intravaginal administration of 0.1 mg/kg; additionally, rabbits were dosed with 0.5 mg/kg intravaginally. In rabbits (n = 6), mean (+/- SD) peak concentrations following iv bolus administration were 1554 +/- 296 ng/mL. The weight-normalized clearance (CL/W) was 5.9 +/- 0.4 mL/min/kg, initial volume of distribution (V1/W) was 57 +/- 9 mL/kg, and volume of distribution at steady state (V(ss)/W), assuming central compartment elimination, was 240 +/- 20 Ml/kg. V(ss)/W could be as large as 2000 +/- 400 Ml/kg without this assumption. The estimated amounts of rhr1x absorbed in rabbits following intravaginal administration of 0.1 and 0.5 mg/kg (n = 5/dose) were 3.1 +/- 1.4 and 0.7 +/- 0.3%, respectively, peak concentrations were 600 +/- 297 and 1066 +/- 584 pg/mL, respectively. In rhesus monkeys (n = 5) after iv administration, peak concentrations were 971 +/- 277 ng/mL; CL/W was 4.1 +/- 0.6 mL/min/kg, V1/W was 78 +/- 25 mL/kg, and V(ss)/W, assuming central compartment elimination, was 690 +/- 220 mL/kg. The upper limit for V(ss)/W was 1600 +/- 200 mL/kg when no assumptions were made regarding site (compartment) of elimination. After intravaginal administration (n = 6), two monkeys had undetectable rhR1x concentrations throughout the 48-hr sampling interval; one monkey had only one sample containing measurable rhR1x (51 pg/mL) at 24 hr; and three monkeys absorbed <2% of the 0.1 mg/kg dose. Peak concentrations in these three animals ranged from 64 to 1475 pg/mL. The absorption of rhR1x was low and variable in both species, and similar results have been observed in women.
引用
收藏
页码:223 / 227
页数:5
相关论文
共 17 条
  • [1] BAYESIAN-ANALYSIS OF MINIMUM AIC PROCEDURE
    AKAIKE, H
    [J]. ANNALS OF THE INSTITUTE OF STATISTICAL MATHEMATICS, 1978, 30 (01) : 9 - 14
  • [2] ABSORPTION FROM THE VAGINA
    BENZIGER, DP
    EDELSON, J
    [J]. DRUG METABOLISM REVIEWS, 1983, 14 (02) : 137 - 168
  • [3] CHARACTERIZATION OF CHEMICALLY SYNTHESIZED HUMAN RELAXIN BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
    CANOVADAVIS, E
    BALDONADO, IP
    TESHIMA, GM
    [J]. JOURNAL OF CHROMATOGRAPHY, 1990, 508 (01): : 81 - 96
  • [4] THE PHARMACOKINETICS AND METABOLISM OF HUMAN RELAXINS IN RHESUS-MONKEYS
    FERRAIOLO, BL
    WINSLOW, J
    LARAMEE, G
    CELNIKER, A
    JOHNSTON, P
    [J]. PHARMACEUTICAL RESEARCH, 1991, 8 (08) : 1032 - 1038
  • [5] Gibaldi M., 1982, PHARMACOKINETICS
  • [6] GORDON AJ, 1977, LANCET, V2, P1319
  • [7] AN ENZYME-LINKED IMMUNOSORBENT-ASSAY TO STUDY HUMAN RELAXIN IN HUMAN-PREGNANCY AND IN PREGNANT RHESUS-MONKEYS
    LUCAS, C
    BALD, LN
    MARTIN, MC
    JAFFE, RB
    DROLET, DW
    MORAWORMS, M
    BENNETT, G
    CHEN, AB
    JOHNSTON, PD
    [J]. JOURNAL OF ENDOCRINOLOGY, 1989, 120 (03) : 449 - 457
  • [8] MACLENNAN AH, 1981, OBSTET GYNECOL, V58, P601
  • [9] MACLENNAN AH, 1980, LANCET, V1, P220
  • [10] MACLENNAN AH, 1979, LANCET, V2, P117